2026 NPPES data Hematology & Oncology Physician NPI 1073591525 MD
Verify on CMS →

LAURA WEAKLAND, MD

Hematology & Oncology Physician in MANSFIELD, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
512
Medicare Part D claims · 201 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
68.3891/100
▼ 15 pts below national avg 83.1 · [object Object]

What the federal data shows

LAURA WEAKLAND, MD reported a CMS MIPS final score of 68.3891/100 — below the 83.1 national average — and filed 512 Medicare Part D claims in 2023.

68.3891/100
MIPS score · -15 vs avg
512
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LAURA WEAKLAND, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

68 7th percentile higher than 7% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). This entry sits in this band. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

LAURA WEAKLAND, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LAURA WEAKLAND, MD?

Below national average

NPI registry status

Active

Issued 01/05/2006

NPI 1073591525

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

512 40% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

68.3891/100 14.710899999999995% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Ohio

How Hematology & Oncology Physician compares to other specialties among Ohio providers

Ohio providers

Hematology & Oncology Physician share within Ohio

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Ohio

Medicare quality performance — MIPS

LAURA WEAKLAND, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
68.3891/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 68.3891/100 vs national avg 83.1

0%100%National avg83%68.4%
MIPS final score (Hematology & Oncology Physician) — 68.3891/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LAURA WEAKLAND, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 335 GLESSNER AVE, MANSFIELD, OH, 44903, with a listed phone of (419) 756-2003. NPI 1073591525 was issued on 01/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WEAKLAND most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 512 prescription claims written by this provider, covering 201 Medicare beneficiaries and totaling roughly $427K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 4.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 68.3891/100 for the 2023 performance year (Quality 70.8255, Cost 40.249), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

335 GLESSNER AVE
MANSFIELD, OH 44903

Provider Details

NPI 1073591525
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 01/05/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

68.3891
Final Score
Avg: 83.1
70.8255
Quality
40.249
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where LAURA WEAKLAND, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

OHIOHEALTH CORPORATION
MANSFIELD, OH

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to LAURA WEAKLAND, MD. To verify LAURA WEAKLAND, MD's current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

LAURA WEAKLAND, MD — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 512 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

512
Total Claims
$427K
Total Drug Cost
201
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
900
Total Day Supply
25,250
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$350K
Generic Drug Cost
$78K
Opioid Claims
22 (4.3% rate)
Antibiotic Claims
14

Patient Demographics

Average Patient Age
73.4 years
Avg HCC Risk Score
1.66
Gender Split
80% female / 20% male
Age Distribution
<65: 16, 65-74: 102, 75-84: 64, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LAURA WEAKLAND, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
105
Letrozole
56
Prednisone
29
Acyclovir
26
Tamoxifen Citrate
19
Xarelto
Rivaroxaban
19
Eliquis
Apixaban
16
Hydroxyurea
13
Gabapentin
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How LAURA WEAKLAND, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

LAURA WEAKLAND, MD's 512 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as WEAKLAND.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LAURA WEAKLAND, MD's specialty?
LAURA WEAKLAND, MD specializes in Hematology & Oncology Physician and practices in MANSFIELD, Ohio. Credentials: MD.
How much does LAURA WEAKLAND, MD prescribe under Medicare Part D?
In 2023, LAURA WEAKLAND, MD wrote 512 Medicare Part D claims totaling $427K in drug costs for 201 beneficiaries.
What is LAURA WEAKLAND, MD's Medicare quality score?
LAURA WEAKLAND, MD has a CMS MIPS Final Score of 68.3891/100 (Quality: 70.8255, Cost: 40.249). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is LAURA WEAKLAND, MD located?
LAURA WEAKLAND, MD is located at 335 GLESSNER AVE, MANSFIELD, OH, 44903. Phone: (419) 756-2003.
What is LAURA WEAKLAND, MD's NPI number?
LAURA WEAKLAND, MD's National Provider Identifier (NPI) is 1073591525, issued on 01/05/2006.
Does LAURA WEAKLAND, MD prescribe more brand-name or generic drugs?
LAURA WEAKLAND, MD's prescribing is 13% brand-name and 87% generic drugs by claim count, with $350K in brand drug costs.
Does LAURA WEAKLAND, MD prescribe opioids?
Yes, LAURA WEAKLAND, MD had 22 opioid claims in 2023 with an opioid prescribing rate of 4.3%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does LAURA WEAKLAND, MD prescribe most often?
Based on 2023 Medicare Part D data, LAURA WEAKLAND, MD's most frequently prescribed drugs include Anastrozole, Letrozole, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LAURA WEAKLAND, MD accept Medicare?
LAURA WEAKLAND, MD appears in CMS Medicare data with 512 Part D claims and 201 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LAURA WEAKLAND, MD's credentials?
LAURA WEAKLAND, MD's NPI is 1073591525 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology